Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma

Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma

Abstract Background Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the fourth leading cause of cancer-related death worldwide. Sorafenib is currently acknowledged as a standard therapy for advanced HCC. However, acquired resistance substantially limits the clinical efficacy o...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Danyang Li, Yingcheng Yao, Yuhan Rao, Xinyu Huang, Li Wei, Zhimei You, Guo Zheng, Xiaoli Hou, Yu Su, Zac Varghese, John F. Moorhead, Yaxi Chen, Xiong Z. Ruan
Materialtyp: Artikel
Språk:English
Publicerad: BMC 2022-03-01
Serie:Journal of Experimental & Clinical Cancer Research
Ämnen:
Sorafenib resistant
SCAP
Autophagy
Lycorine
Hepatocellular carcinoma (HCC)
Länkar:https://doi.org/10.1186/s13046-022-02306-4

Internet

https://doi.org/10.1186/s13046-022-02306-4

Liknande verk